| Date | Document |
|---|---|
| 10/09/2020 | Proposed issue of Securities - RHT |
| 10/09/2020 | Execution of Licence Agreement |
| 20/08/2020 | Preliminary Final Report |
| 28/07/2020 | Appendix 4C - quarterly |
| 26/05/2020 | Additional Information on Announcement Dated 25 May 2020 |
| 25/05/2020 | Resonance Health Files New Provisional Patent |
| 28/04/2020 | Appendix 4C - quarterly |
| 06/04/2020 | 510(k) Application Submission to U.S. FDA |
| 31/03/2020 | Market Update |
| 20/03/2020 | Secondary Trading Notice & Appendix 2A |
| 19/03/2020 | Proposed issue of Securities - RHT |
| 19/03/2020 | Controlled Placement Facility |
| 06/03/2020 | Secondary Trading Notice & Appendix 2A |
| 21/02/2020 | Half Yearly Report and Accounts |
| 04/02/2020 | Licencee & Royalty Agreement with 3DR Laboratories |
| 29/01/2020 | Appendix 4C - quarterly |
| 13/01/2020 | Appendix 3B and Secondary Trading Notice |